Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and Rhabdoid Tumor

pyrroles has been researched along with Rhabdoid Tumor in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Alt, J; Eberhart, CG; Figg, WD; Findlay, TR; Kaur, H; Malebranche, KJ; Maxwell, MJ; Odabas, A; Parkhurst, A; Peer, CJ; Raabe, EH; Rubens, JA; Slusher, BS; Wang, SZ; Warren, KE1
Broncel, M; Crosier, S; Daley, F; Finetti, MA; Holmes, K; Huang, PH; Jenks, A; Luczynski, MT; McCarthy, F; Natrajan, RC; Payne, LS; Ryall, KA; Tan, AC; Tanos, B; Todd, JR; Vyse, S; Wai, P; Williamson, D; Wong, JP1
Foster, K; Wang, Y; Wright, C; Zhou, D1
Ceresoli, GL; Colombo, P; De Sanctis, R; De Vincenzo, F; Gianoncelli, L; Graziotti, P; Lorenzi, E; Perrino, M; Santoro, A; Simonelli, M; Zucali, PA1

Other Studies

4 other study(ies) available for pyrroles and Rhabdoid Tumor

ArticleYear
Dual mTORC1/2 inhibition compromises cell defenses against exogenous stress potentiating Obatoclax-induced cytotoxicity in atypical teratoid/rhabdoid tumors.
    Cell death & disease, 2022, 04-28, Volume: 13, Issue:4

    Topics: Animals; Humans; Indoles; Mechanistic Target of Rapamycin Complex 1; Mice; Pyrroles; Rhabdoid Tumor; TOR Serine-Threonine Kinases

2022
Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors.
    Cell reports, 2016, 10-25, Volume: 17, Issue:5

    Topics: Apoptosis; Cell Line, Tumor; Dasatinib; Drug Resistance, Neoplasm; Gene Expression Profiling; Humans; Indazoles; Indoles; Oncogenes; Pyrimidines; Pyrroles; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Platelet-Derived Growth Factor alpha; Rhabdoid Tumor; Sulfonamides; Sunitinib

2016
Dependence on PI3K/Akt signaling for malignant rhabdoid tumor cell survival.
    Cancer chemotherapy and pharmacology, 2009, Volume: 63, Issue:5

    Topics: Blotting, Western; Cell Proliferation; Cell Survival; HeLa Cells; Humans; Immunoprecipitation; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyrimidines; Pyrroles; ras Proteins; Receptor, IGF Type 1; Rhabdoid Tumor; Signal Transduction; Tumor Cells, Cultured

2009
Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Jun-20, Volume: 29, Issue:18

    Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Cell Dedifferentiation; Combined Modality Therapy; Female; Humans; Hypothyroidism; Indoles; Kidney Neoplasms; Lung Neoplasms; Middle Aged; Nephrectomy; Peripheral Nervous System Diseases; Protein Kinase Inhibitors; Pyrroles; Remission Induction; Rhabdoid Tumor; Sunitinib

2011